Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection.
about
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemicCurrent concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciAntimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials.Molecular characterization of resistance to Rifampicin in an emerging hospital-associated Methicillin-resistant Staphylococcus aureus clone ST228, SpainSynthesis and Antibacterial Evaluation of (S,Z)-4-methyl-2-(4-oxo-5-((5-substituted phenylfuran-2-yl) methylene)-2-thioxothiazolidin-3-yl)Pentanoic Acids.Methicillin-resistant Staphylococcus aureus in HIV-infected patients.Community-Associated Methicillin-Resistant Staphylococcus aureus: An Enemy amidst UsCharacterization of Staphylococcus aureus Isolates That Colonize Medical Students in a Hospital of the City of Cali, Colombia.Drug interactions modulate the potential for evolution of resistance.In Vitro and In Vivo Synergy of the Oxadiazole Class of Antibacterials with β-Lactams.Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge.Recurrent furunculosis - challenges and management: a review.Diagnosis and management of skin and soft-tissue infections (SSTI): a literature review and consensus statement on behalf of the Italian Society of Infectious Diseases and International Society of Chemotherapy.Mini-review: Staphylococcus epidermidis as the most frequent cause of nosocomial infections: old and new fighting strategies.Tackling Threats and Future Problems of Multidrug-Resistant Bacteria.Impact of Glycopeptide Resistance in Staphylococcus aureus on the Dalbavancin In Vivo Pharmacodynamic Target.Antimicrobial Properties of Selected Copper Alloys on Staphylococcus aureus and Escherichia coli in Different Simulations of Environmental Conditions: With vs. without Organic Contamination.Anti-inflammatory and anti-superbacterial activity of polyphenols isolated from black raspberry.Efficacy of usual and high doses of daptomycin in combination with rifampin versus alternative therapies in experimental foreign-body infection by methicillin-resistant Staphylococcus aureus.New antibiotics for antibiotic-resistant bacteria.Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms.Synthesis and biological evaluation of (E)-1-(substituted)-3-phenylprop-2-en-1-ones bearing rhodanines as potent anti-microbial agents.The first report in Brazil of severe infection caused by community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA).Anti-MRSA drug use and antibiotic susceptibilities of MRSA at a university hospital in Japan from 2007 to 2011.Outpatient management of cholesteatoma with canal wall reconstruction tympanomastoidectomy.Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).Design, Synthesis, and Antibacterial Evaluation of Oxazolidinones with Fused Heterocyclic C-Ring Substructure.Negative impact of linezolid on human neutrophil functions in vitro.Methicillin-Resistant Staphylococcus aureus (MRSA) Staphylococcal Cassette Chromosome mec Genotype Effects Outcomes of Patients With Healthcare-Associated MRSA Bacteremia Independently of Vancomycin Minimum Inhibitory Concentration
P2860
Q24614464-F9811147-B5BE-4FF9-838B-62B85F10A525Q26853465-F3167F30-C01C-4E93-A073-80B5995D5B45Q28393128-EC523FBD-9BE6-49F7-9F44-6CF472E7D5D5Q33536820-A21AFFCD-A8B0-472D-81C0-352E5541A1FCQ34777743-EDEF3364-BB7C-4410-AEFE-2ED851B02609Q35026548-8D662D37-F18A-4A5A-98D4-BFE775D1D972Q36155088-5E379D29-3900-4C20-8693-30B4256C4B97Q36162837-10274466-2C5F-418A-914C-C8A6D1B5CF74Q36937085-9446054F-5E0C-42E2-B399-EB739BBB7B53Q37203885-7698CDEB-A6A1-4986-9A0B-E4227A5E95D5Q37392891-1D714BDF-B97F-4C08-B701-A2B65C55D829Q37602969-62BF28C2-B22B-4D92-A10C-DDAD8E0B0EB3Q37946595-1B91A561-BA04-4D76-B48A-76267A5CF587Q38166786-4EF879E4-1B1D-44B1-AD81-9D7E22BADC42Q38842620-4A1B7E72-53BD-42EC-B74D-A1FBD1EACB9FQ40988669-5AB83B6B-5217-42AC-AAA4-303AF9A3A75BQ41339078-18E508DE-5C77-4CCD-B196-4A842D9A41F2Q41863895-7164FAF2-AD28-407D-A6E4-27FF81C9603AQ42036509-73744384-9538-4887-9C65-8900277FDBBAQ42183500-4BBC9445-E3E6-419C-9D43-440704372A1DQ42218026-E3500C45-F444-4BB7-A071-EDCE504BEA00Q43559467-41899A5E-F2EE-4F33-9C34-3E93E4F20284Q44509330-C07EDDB8-788F-46DB-A9F6-D030338BF249Q46708063-51006F16-5917-4C6A-AB80-0FA56BBF9513Q47150724-7A8601D1-5DF7-4C24-A61D-1DFF6CA9D376Q49833719-9D554391-D4BE-480B-B794-8633DF712115Q49897544-AE5C9459-ED20-4DFB-86A6-1A24DE695EECQ54333201-8B27E2AB-1B3B-4F15-BD6B-BD593F5933B7Q58815286-3DEBCCE7-7FEF-4EFC-BCB9-07B04CFE9952
P2860
Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current treatment options for ...... aphylococcus aureus infection.
@en
Current treatment options for ...... aphylococcus aureus infection.
@nl
type
label
Current treatment options for ...... aphylococcus aureus infection.
@en
Current treatment options for ...... aphylococcus aureus infection.
@nl
prefLabel
Current treatment options for ...... aphylococcus aureus infection.
@en
Current treatment options for ...... aphylococcus aureus infection.
@nl
P356
P1476
Current treatment options for ...... aphylococcus aureus infection.
@en
P2093
Robert C Moellering
P304
P356
10.1086/529445
P407
P577
2008-04-01T00:00:00Z